von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
- PMID: 8584997
von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
Abstract
Tissue plasminogen activator antigen (tPA), plasminogen activator inhibitor antigen (PAI-1), soluble P-selectin and von Willebrand factor antigen (vWf) were measured by ELISA in 41 patients with peripheral vascular disease (PVD), 41 with ischaemic heart disease (HD) and in 46 age and sex matched asymptomatic controls. Increased vWf was found in patients with IHD (p = 0.0002) and in patients with PVD (p = 0.0011) relative to the controls but levels did not differ between the two patients groups. Raised tPA found in both PVD (p = 0.0006) and IHD (p = 0.0061) compared to the controls also failed to differentiate the two groups of patients. Soluble P-selectin was also raised in both groups (p = 0.003 in IHD and p = 0.0102 in PVD) with no difference between the groups. There were no differences in levels of PAI-1 between the groups. In the subjects taken as a whole, there were significant Spearman's correlations between tPA and vWf (r = 0.37, p < 0.001), tPA and triglycerides (r = 0.38, p < 0.001), tPA and P-selectin (r = 0.19, p = 0.032), vWf and age (r = 0.25, p = 0.005) and inversely between vWf and HDL (r = -0.25, p = 0.006). These data support the concept that increased levels of tPA may be important in atherosclerosis, and indicate that soluble P-selectin may be useful in further analysis of the role of platelets and the endothelial cell in this disease.
Similar articles
-
Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis.Thromb Haemost. 1994 Jul;72(1):151-4. Thromb Haemost. 1994. PMID: 7526483 Clinical Trial.
-
Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.J Rheumatol. 2002 May;29(5):875-82. J Rheumatol. 2002. PMID: 12022343
-
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.J Hypertens. 1995 Dec;13(12 Pt 2):1674-8. J Hypertens. 1995. PMID: 8903631
-
Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis.Microvasc Res. 2021 Nov;138:104224. doi: 10.1016/j.mvr.2021.104224. Epub 2021 Jul 15. Microvasc Res. 2021. PMID: 34273359 Free PMC article.
-
[Tissue plasminogen activator and plasminogen activator inhibitor gene polymorphisms: possible relation to atherosclerosis and its complications].Kardiologiia. 2003;43(8):60-7. Kardiologiia. 2003. PMID: 14593385 Review. Russian.
Cited by
-
Pathologic thrombopoiesis of rheumatoid arthritis.Rheumatol Int. 2003 Mar;23(2):49-60. doi: 10.1007/s00296-003-0289-0. Epub 2003 Feb 11. Rheumatol Int. 2003. PMID: 12634936 Review.
-
Insulin resistance and vessel endothelial function.J R Soc Med. 2002;95 Suppl 42(Suppl 42):54-61. J R Soc Med. 2002. PMID: 12216328 Free PMC article. Review.
-
Effects of various doses of aspirin on platelet activity and endothelial function.Heart Vessels. 2011 May;26(3):267-73. doi: 10.1007/s00380-010-0054-8. Epub 2010 Nov 10. Heart Vessels. 2011. PMID: 21063876 Clinical Trial.
-
Soluble P-selectin rescues mice from anthrax lethal toxin-induced mortality through PSGL-1 pathway-mediated correction of hemostasis.Virulence. 2017 Oct 3;8(7):1216-1228. doi: 10.1080/21505594.2017.1282027. Epub 2017 Jan 19. Virulence. 2017. PMID: 28102766 Free PMC article.
-
Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.Cardiovasc Diabetol. 2018 Aug 31;17(1):121. doi: 10.1186/s12933-018-0763-3. Cardiovasc Diabetol. 2018. PMID: 30170601 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous